Evotec - Research never stops

Financial Key Figures According to IFRS



2007
2008
08|07 in %

Results*:





Revenues T Euro 32,885 39,613 20
R&D expenses T Euro 36,938 42,537 15
Operating result** T Euro (49,569) (45,627) 8
Net income (loss) T Euro (48,053) (78,287) (63)

Balance sheet data:





Total stockholders' equity T Euro 170,553 149,859 (12)
Capital expenditure*** T Euro 4,349 3,514 (19)
Cash and investments T Euro 93,676 92,401**** (1)
Balance sheet total T Euro 207,878 182,900 (12)
Cash flow T Euro (11,374)***** 15,462 236

Personnel data*:





Employees as of Dec. 31 386 418 8

Per share*:





Result Euro (0.67) (0.82) (22)

*2007 excluding contributions from Evotec Technologies and from the Chemical Development Business. **Before impairment.
*** Cash relevant purchase of tangible and intangible assets, excluding finance leases.
**** Including auction rate securities.
***** Including contributions from Evotec Technologies and from the Chemical Development Business.